TR202016869A1 - Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu - Google Patents

Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu

Info

Publication number
TR202016869A1
TR202016869A1 TR2020/16869A TR202016869A TR202016869A1 TR 202016869 A1 TR202016869 A1 TR 202016869A1 TR 2020/16869 A TR2020/16869 A TR 2020/16869A TR 202016869 A TR202016869 A TR 202016869A TR 202016869 A1 TR202016869 A1 TR 202016869A1
Authority
TR
Turkey
Prior art keywords
lavender
essential oils
french
synergic combination
synergic
Prior art date
Application number
TR2020/16869A
Other languages
English (en)
Inventor
Esra Karadağ Ayşe
Çaşkurlu Ayşegül
Tosun Fatma
Demi̇rci̇ Fati̇h
Original Assignee
Istanbul Medipol Ueniversitesi
Anadolu Ueniversitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istanbul Medipol Ueniversitesi, Anadolu Ueniversitesi filed Critical Istanbul Medipol Ueniversitesi
Priority to TR2020/16869A priority Critical patent/TR202016869A1/tr
Priority to PCT/TR2021/051001 priority patent/WO2022086467A1/en
Publication of TR202016869A1 publication Critical patent/TR202016869A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/235—Foeniculum (fennel)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, lavanta ve rezene uçucu yağlarını içeren bir farmasötik bileşime ilişkindir.
TR2020/16869A 2020-10-22 2020-10-22 Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu TR202016869A1 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2020/16869A TR202016869A1 (tr) 2020-10-22 2020-10-22 Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu
PCT/TR2021/051001 WO2022086467A1 (en) 2020-10-22 2021-10-01 Synergistic combination of lavender and fennel essential oils

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2020/16869A TR202016869A1 (tr) 2020-10-22 2020-10-22 Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu

Publications (1)

Publication Number Publication Date
TR202016869A1 true TR202016869A1 (tr) 2022-05-23

Family

ID=78528992

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2020/16869A TR202016869A1 (tr) 2020-10-22 2020-10-22 Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu

Country Status (2)

Country Link
TR (1) TR202016869A1 (tr)
WO (1) WO2022086467A1 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210213156A1 (en) * 2018-05-14 2021-07-15 The Regents Of The University Of Michigan Long lasting antimicrobial surfaces based on the cross-linking of natural oils within polymer networks
CN111298124A (zh) * 2020-03-30 2020-06-19 黄泳华 含有抗生素与植物油的抗痤疮组合物

Also Published As

Publication number Publication date
WO2022086467A1 (en) 2022-04-28

Similar Documents

Publication Publication Date Title
CO2018011105A2 (es) 6-hidroxi-4-oxo-1,4-dihidropirimidin-5-carboxamidas como agonistas del receptor de apelina (apj)
EA201990495A1 (ru) Биарильные соединения, применимые в качестве иммуномодуляторов
UY38076A (es) Derivados de tetrahidroquinazolina útiles como agentes anticáncer
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
BR112018007395A2 (pt) 2,4-di-hidróxi-nicotinamidas como agonistas de apj
CU20220005A7 (es) Inhibidores tricíclicos de kars dependientes de akr1c3
HN2012000437A (es) Nuevos agentes anticancer y la preparacion de dichos agentes
CO6690805A2 (es) 6-amino-nicotinamidas sustituidas como modulares de kcnq2/3
PA8846901A1 (es) Inhibidores de cinasa akt y p70 s6.
DOP2006000096A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
CL2019001631A1 (es) Formulación de mezcla que comprende células y un ácido graso poliinsaturado que tiene al menos 20 átomos de carbono (lc-pufa).
BR112022008294A2 (pt) Composições de profármaco e métodos de tratamento
ECSP14004595A (es) 2-tiopirimidinonas
EA201990159A1 (ru) Биарилметильные гетероциклы
DOP2012000250A (es) COMPUESTOS DEL COMPLEJO DE Fe(III) PARA EL TRATAMIENTO Y PROFILAXIS DE LOS SÍNTOMAS DE DEFICIENCIA DE HIERRO Y LAS ANEMIAS POR DEFICIENCIA DE HIERRO
ECSP088202A (es) Composición farmacéutica sólida que comprende 1-(4-cloro-anilino)-4-(4-piridil-metil)-ftalazina y un modificador del ph
CO2018003744A2 (es) Fibras minerales
ECSP13012453A (es) 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3
BR112015027796A2 (pt) Microcápsulas que contêm um cetoácido ou cetoéster fotolábil gerador de gás e uso das mesmas
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
TR202016869A1 (tr) Lavanta ve rezene uçucu yağlarinin si̇nerji̇k kombi̇nasyonu
CL2023001747A1 (es) Composición farmacéutica de agonistas duales de glp-1/glp-2
EA201990162A1 (ru) Фармацевтические композиции
MX2019001303A (es) Compuestos organicos.
BR112023001803A2 (pt) Odorantes e composições compreendendo odorantes